The University of Chicago Header Logo

Connection

Amittha Wickrema to Cell Line, Tumor

This is a "connection" page, showing publications Amittha Wickrema has written about Cell Line, Tumor.
Connection Strength

0.296
  1. Expression of functional folate receptors in multiple myeloma. Leuk Lymphoma. 2018 12; 59(12):2982-2989.
    View in: PubMed
    Score: 0.106
  2. Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. Leuk Lymphoma. 2009 Nov; 50(11):1865-71.
    View in: PubMed
    Score: 0.059
  3. Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3. Leuk Lymphoma. 2008 Oct; 49(10):1945-53.
    View in: PubMed
    Score: 0.055
  4. Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells. J Clin Invest. 2018 12 03; 128(12):5479-5488.
    View in: PubMed
    Score: 0.028
  5. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015 May 14; 125(20):3144-52.
    View in: PubMed
    Score: 0.021
  6. High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma. Biochem Biophys Res Commun. 2009 Jul 24; 385(2):160-4.
    View in: PubMed
    Score: 0.014
  7. Activation of protein kinase C{eta} by type I interferons. J Biol Chem. 2009 Apr 17; 284(16):10301-14.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.